Mutation of GALNTL5 gene identified in patients diagnosed with asthenozoospermia

Jun Hagiuda, Nobuyoshi Takasaki, Mototsugu Oya, Hiromichi Ishikawa, Hisashi Narimatsu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Asthenozoospermia is commonly observed in infertile men. However, very few causative gene mutations have been identified because an efficient detection method has not been established. We previously identified a patient with asthenozoospermia carrying a heterozygous point deletion in GALNTL5 by detecting an abnormal reduction in the abundance of GALNTL5 and other marker proteins. To identify other mutations in GALNTL5, we screened sperm samples from 208 infertile men mainly diagnosed with asthenozoospermia using the same method, and conducted next-generation sequencing. Consequently, another case of GALNTL5 mutation was detected only in sperm at a low frequency but not in the somatic blood cells of a patient diagnosed with asthenozoospermia. In this patient, sperm motility improved and the mutation disappeared at 2 years after the first observation. In this man, carrying a heterozygotic deficiency of GALNTL5, the swim-up method was useful to concentrate the spermatozoa without mutation. Intracytoplasmic sperm injection of the selected motile spermatozoa into oocytes of the patient’s partner resulted in successful conception, and a female child was safely delivered. These results suggest the feasibility of our approach for the screening and treatment of asthenozoospermia associated with GALNTL5 mutation.

Original languageEnglish
JournalHuman Fertility
DOIs
Publication statusAccepted/In press - 2019 Jan 1

Fingerprint

Asthenozoospermia
Mutation
Spermatozoa
Genes
Intracytoplasmic Sperm Injections
Sperm Motility
Oocytes
Blood Cells
Observation

Keywords

  • Asthenozoospermia
  • GALNTL5
  • intracytoplasmic sperm injection
  • spermatogonial mutation
  • swim-up method

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

Mutation of GALNTL5 gene identified in patients diagnosed with asthenozoospermia. / Hagiuda, Jun; Takasaki, Nobuyoshi; Oya, Mototsugu; Ishikawa, Hiromichi; Narimatsu, Hisashi.

In: Human Fertility, 01.01.2019.

Research output: Contribution to journalArticle

Hagiuda, Jun ; Takasaki, Nobuyoshi ; Oya, Mototsugu ; Ishikawa, Hiromichi ; Narimatsu, Hisashi. / Mutation of GALNTL5 gene identified in patients diagnosed with asthenozoospermia. In: Human Fertility. 2019.
@article{91f11bc3793849abb5d01a0c8031763f,
title = "Mutation of GALNTL5 gene identified in patients diagnosed with asthenozoospermia",
abstract = "Asthenozoospermia is commonly observed in infertile men. However, very few causative gene mutations have been identified because an efficient detection method has not been established. We previously identified a patient with asthenozoospermia carrying a heterozygous point deletion in GALNTL5 by detecting an abnormal reduction in the abundance of GALNTL5 and other marker proteins. To identify other mutations in GALNTL5, we screened sperm samples from 208 infertile men mainly diagnosed with asthenozoospermia using the same method, and conducted next-generation sequencing. Consequently, another case of GALNTL5 mutation was detected only in sperm at a low frequency but not in the somatic blood cells of a patient diagnosed with asthenozoospermia. In this patient, sperm motility improved and the mutation disappeared at 2 years after the first observation. In this man, carrying a heterozygotic deficiency of GALNTL5, the swim-up method was useful to concentrate the spermatozoa without mutation. Intracytoplasmic sperm injection of the selected motile spermatozoa into oocytes of the patient’s partner resulted in successful conception, and a female child was safely delivered. These results suggest the feasibility of our approach for the screening and treatment of asthenozoospermia associated with GALNTL5 mutation.",
keywords = "Asthenozoospermia, GALNTL5, intracytoplasmic sperm injection, spermatogonial mutation, swim-up method",
author = "Jun Hagiuda and Nobuyoshi Takasaki and Mototsugu Oya and Hiromichi Ishikawa and Hisashi Narimatsu",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/14647273.2018.1562239",
language = "English",
journal = "Human Fertility",
issn = "1464-7273",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Mutation of GALNTL5 gene identified in patients diagnosed with asthenozoospermia

AU - Hagiuda, Jun

AU - Takasaki, Nobuyoshi

AU - Oya, Mototsugu

AU - Ishikawa, Hiromichi

AU - Narimatsu, Hisashi

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Asthenozoospermia is commonly observed in infertile men. However, very few causative gene mutations have been identified because an efficient detection method has not been established. We previously identified a patient with asthenozoospermia carrying a heterozygous point deletion in GALNTL5 by detecting an abnormal reduction in the abundance of GALNTL5 and other marker proteins. To identify other mutations in GALNTL5, we screened sperm samples from 208 infertile men mainly diagnosed with asthenozoospermia using the same method, and conducted next-generation sequencing. Consequently, another case of GALNTL5 mutation was detected only in sperm at a low frequency but not in the somatic blood cells of a patient diagnosed with asthenozoospermia. In this patient, sperm motility improved and the mutation disappeared at 2 years after the first observation. In this man, carrying a heterozygotic deficiency of GALNTL5, the swim-up method was useful to concentrate the spermatozoa without mutation. Intracytoplasmic sperm injection of the selected motile spermatozoa into oocytes of the patient’s partner resulted in successful conception, and a female child was safely delivered. These results suggest the feasibility of our approach for the screening and treatment of asthenozoospermia associated with GALNTL5 mutation.

AB - Asthenozoospermia is commonly observed in infertile men. However, very few causative gene mutations have been identified because an efficient detection method has not been established. We previously identified a patient with asthenozoospermia carrying a heterozygous point deletion in GALNTL5 by detecting an abnormal reduction in the abundance of GALNTL5 and other marker proteins. To identify other mutations in GALNTL5, we screened sperm samples from 208 infertile men mainly diagnosed with asthenozoospermia using the same method, and conducted next-generation sequencing. Consequently, another case of GALNTL5 mutation was detected only in sperm at a low frequency but not in the somatic blood cells of a patient diagnosed with asthenozoospermia. In this patient, sperm motility improved and the mutation disappeared at 2 years after the first observation. In this man, carrying a heterozygotic deficiency of GALNTL5, the swim-up method was useful to concentrate the spermatozoa without mutation. Intracytoplasmic sperm injection of the selected motile spermatozoa into oocytes of the patient’s partner resulted in successful conception, and a female child was safely delivered. These results suggest the feasibility of our approach for the screening and treatment of asthenozoospermia associated with GALNTL5 mutation.

KW - Asthenozoospermia

KW - GALNTL5

KW - intracytoplasmic sperm injection

KW - spermatogonial mutation

KW - swim-up method

UR - http://www.scopus.com/inward/record.url?scp=85059901971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059901971&partnerID=8YFLogxK

U2 - 10.1080/14647273.2018.1562239

DO - 10.1080/14647273.2018.1562239

M3 - Article

AN - SCOPUS:85059901971

JO - Human Fertility

JF - Human Fertility

SN - 1464-7273

ER -